PMV Pharmaceuticals' Series B Round

PMV Pharmaceuticals raised a round of funding on February 22, 2017.

PMV Pharma is engaged in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer and infectious disease.…

Articles about PMV Pharmaceuticals' Series B Round: